In conclusion, we demonstrated that IR NKG2A is differentially expressed by Tex cell with a given TCR established during tumor and chronic viral infection development, which further dictates the differential responses of disease‐specific Tex cells to NKG2A blockade. This evidence concerns the gene KLRC1 and neoplasm.